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Objective: To assess the frequency of cystic lung disease suggestive of pulmonary lymphangio-
myomatosis in men with tuberous sclerosis complex.
Patients and methods: Retrospective review of CT scans of the chest and abdomen on 29 men
with tuberous sclerosis complex encountered during a 13-year period, 1998 to 2010.
Results: Cystic lung disease (defined as 4 cysts) was seen in 11 of 29 men (38%) with tuberous
sclerosis complex. The mean age of those with cystic lung disease was 46.3  19.1 years. None
of the patients had experienced pneumothorax or chylothorax and none had undergone a lung
biopsy for evaluation of cystic lung disease. Lymphangiomyomatosis had been diagnosed in two
of 11 patients with cystic lung disease. Renal angiomyolipomas were demonstrated in 14 of 25
patients (56%) with renal imaging available; all 14 had multiple bilateral renal involvement. In
this limited cohort of patients, the presence of cystic lung disease did not correlate with age,
smoking exposure or the presence of renal AMLs.
Conclusion: We conclude that tuberous sclerosis complex -related lymphangiomyomatosis may
not be rare in men but is milder in severity.
ª 2012 Elsevier Ltd. All rights reserved.DLCO, Single breath diffusing
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Tuberous sclerosis complex (TSC) is an inheritable disorder
(autosomal dominant) characterized by multisystem
hamartomas.1e3 The prevalence of TSC is estimated to be
nearly 1 per 10,000 persons.1 Males and females are
affected equally. Approximately 60% of TSC patients have
no prior family history of disease and appear to represent.
Cystic lung disease in men with TSC 1587new mutations.1 TSC is associated with highly variable
expressivity and the clinical features are age-dependent.1,4
Pulmonary involvement in TSC manifests mainly as
pulmonary lymphangiomyomatosis (LAM) or micronodular
pneumocyte hyperplasia.5e9 LAM occurring in patients with
TSC is associated with diffuse cystic lung lesions as depicted
on high-resolution CT (HRCT) scanning of the chest and
appears identical to sporadic LAM.10 In both instances, LAM
is characterized histologically by infiltration and prolifera-
tion of atypical smooth muscle-like cells (“LAM cells”) in
the lung.11,12 Pneumothorax and chylothorax are well-
recognized complications of LAM in both groups but TSC
stigmata such as central nervous system, retinal, and skin
lesions are not seen in patients with sporadic LAM.11,12
Sporadic LAM has been shown to affect almost exclu-
sively women.11,12 Similarly, TSC-LAM has also been thought
to occur mostly in women and only rarely in men with TSC
but lung involvement in men with TSC has not been
adequately explored.6e9,13 In this study, we assessed the
frequency of cystic lung disease suggestive of LAM in men
with TSC by retrospectively studying CT scans available in
such patients seen at our medical centers.
Patients and methods
A computer-assisted search of medical records was con-
ducted to identify men (aged 18 years or older) with TSC
seen at Mayo Clinic, Rochester, MN and Jacksonville, FL
during a 13-year-period between Jan. 1, 1998 and Dec. 31,
2010. Approval was obtained from the Mayo Foundation
Institutional Review Board prior to beginning the study.
All subjects included in this study fulfilled the current
consensus criteria for definite TSC.3 We identified those
who had undergone a CT scan of the chest and also included
those who had undergone CT scan of the abdomen on which
the lung parenchyma could be adequately evaluated with
views of the lung extending above the dome of the dia-
phragm as previously described.14 Of 44 men with TSC
identified, CT scan of the chest or abdomen was available in
29 patients (66%) and included 17 with CT chest and 23 with
CT abdomen (11 had both CT chest and abdomen).
The CT scans were reviewed by two of the authors (JHR,
AGS) independently to identify cystic lesions (defined asTable 1 Demographic and clinical characteristics of 29 men wi
Characteristic With cysts(n Z 11)
Age, yr, median (range) 41 (25e76)
Ethnicity, no. (%)
Caucasian 10 (91)
Hispanic 1 (9)
Smoking status, no. (%)
Never 5 (45)
Previous 3 (27)
Current 3 (27)
Renal AMLs, no. (%)
Present 6 (55)
Absent 2 (18)
Unknown 3 (27)
AML Z angiomyolipoma; TSC Z tuberous sclerosis complex.round lucency with a definable thin wall) in the lung. The
number and sizes of the cysts in the lung were noted.
Differences in interpretation were settled by consensus. As
previously described, the presence of 4 or more cysts in the
lungs was designated to be abnormal.14 Medical records of
these patients were reviewed to extract data regarding
age, sex, smoking history, clinical presentation, imaging
studies, biopsy procedures, and diagnoses.
Statistical analysis
Subjects with lung cysts versus those without lung cysts
were compared using the two-sample rank sum test for
continuous variables and the chi-square (exact) test for
categorical variables. In all cases p-values <0.05 were
considered statistically significant.Results
The mean age of the 29 men with TSC was 34.9  16.8 years
(Table 1). More than one-half were nonsmokers. TSC
mutation analysis had been performed in 6 patients with
mutation detected in TSC1 gene in 2 patients and TSC2
gene in 4 patients. Twenty five patients (86%) had under-
gone a CT abdomen or ultrasonography of the kidneys; 14 of
these patients (56% of those with kidney imaging) had renal
angiomyolipomas (AMLs). The indication for performing
abdominal imaging was to assess for the presence of renal
AMLs in all patients. All of those with renal AMLs had
multiple tumors and bilateral involvement. Indications for
chest CT included abnormal chest radiography (6 patients),
cough (2 patients), dyspnea (2 patients), chest pain (2
patients), staging of suspected renal neoplasm (2 patients),
weight loss (1 patient), and assessment for possible LAM (2
patients). Chest radiographic abnormalities that led to
chest CT included increased interstitial markings (3
patients), lung nodule (2 patients), and focal infiltrate (1
patient).
Among 29 men with TSC, 11 (38%) had cystic lung disease
(defined as 4 cysts) demonstrated on CT chest or abdomen
(Table 2). The cystic lung lesions were identified by CT
chest in 8 patients and by CT abdomen in the remaining 3th TSC.
Without cysts(n Z 18) All(n Z 29)
36 (18e74) 38 (18e76)
17 (94) 27 (93)
1 (6) 2 (7)
13 (72) 18 (62)
5 (28) 8 (28)
0 (0) 3 (10)
8 (44) 14 (48)
9 (50) 11 (38)
1 (6) 4 (14)
Table 2 Eleven men with TSC and cystic lung disease.
Age (yr) Smoking Renal AML CT type Indication for CT Lung
cysts, No.
Pulmonary
function
Follow-up data
25 Never NA Chest Cardiac mass 6 NA NA
30 Never Numerous,
bilateral
Abdomen AML >10 NA NA
30 Never Numerous,
bilateral
Chest Dyspnea >10 NA NA
31 Current Numerous,
bilateral
Chest Focal infiltrate >10 Moderate
obstruction,
mildly
reduced DLCO
Mild progression
115 months later
33 Never Numerous,
bilateral
Chest LAM? 9 NA NA
41 Current Numerous,
bilateral
Abdomen Pain, AML >10 NA NA
45 Current Numerous,
bilateral
Chest LAM? 7 NA NA
55 Never NA Chest Interstitial
infiltrates
>10 Moderate
obstruction,
mildly reduced DLCO
No radiologic
change 13 months
later
70 Previous No Abdomen Aortic aneurysm 10 NA NA
73 Previous NA Chest Chronic cough >10 Moderate
obstruction,
normal DLCO
NA
76 Previous No Chest Chronic cough 9 Mild obstruction,
mildly
reduced DLCO
NA
AML Z angiomyolipoma; DLCO Z Single breath diffusing capacity of the lung for carbon monoxide; LAM? Z evaluation for possible
lymphangioleiomyomatosis; NA Z data not available; TSC Z tuberous sclerosis complex US Z ultrasonography.
Figure 1 High-resolution CT of the chest on a 55-year-old
man with TSC reveals diffuse cystic changes in both lungs.
Pulmonary function testing on this asymptomatic patient
showed a mild obstructive pattern with FEV1 measuring 68%
predicted.
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patients with cystic lung disease were clinically diagnosed
to have TSC-related LAM based on the chest CT findings.
TSC mutation analysis had been performed in only one of
these 11 patients and demonstrated a TSC2 mutation
(IVS7þ1G- > A mutation). In six of these patients (55%) with
cystic lung disease, the presence of cysts had not been
reported in the original radiology interpretation (4 CT chest
and 2 CT abdomen). Two patients with most extensive
cystic changes were 55 (Fig. 1) and 73 years old, respec-
tively. However, there was no significant difference in the
age of those with or without cystic lung disease (46.3  19.1
vs. 35.5  38.6 years [mean  SD], PZ 0.37). The presence
of cystic lung disease was not significantly increased with
prior smoking exposure (55% of smokers vs. 28% of
nonsmokers, PZ 0.24) or in the presence of renal AML (43%
of those with AML vs. 18% of those without, P Z 0.19).
None of the patients with cystic lung disease had expe-
rienced pneumothorax or chylothorax and none of them
had undergone a lung biopsy. Four patients had pulmonary
function results available (Table 2) and all exhibited
a moderate obstructive pattern with forced expiratory
volume in 1 s (FEV1) that measured 61%e68% predicted.
Three of these patients were current or previous smokers.
Single breath diffusing capacity of the lung for carbon
monoxide (DLCO) was normal or mildly reduced (71%e89%
predicted). None of the patients were known to be
hypoxemic or on supplemental oxygen therapy.Two patients had follow-up chest CT scanning available
for review at intervals of 13 and 115 months, respectively.
Mild radiologic progression was noted in the patient with
the longer follow-up (Fig. 2) while the other patient
Figure 2 A. High-resolution CT of the chest on a 31-year-old
man with TSC undergoing evaluation for abnormal chest radi-
ography showing a focal infiltrate that proved to be pneumonia
and subsequently resolved. Several scattered cystic lesions are
seen in both lungs. B. High-resolution CT scan of the chest on
the same patient 115 months later demonstrates mild
progression with enlargement noted in some of the cysts.
Cystic lung disease in men with TSC 1589exhibited stable cystic changes. No follow-up pulmonary
function data were available. None of the patients were on
sirolimus therapy.
Discussion
Although the occurrence of LAM in men with TSC has been
thought to be rare, we find the frequency of cystic lung
disease suggestive of LAM to be relatively high (38%) in men
with TSC, similar to that reported previously for women
with TSC.6e8 Although the diagnosis of LAM in our patients
was not confirmed histologically these results suggest that
the incidence of LAM in men with TSC may be higher than
previously thought and worthy of further exploration.
It has been well-established that sporadic LAM is very rare
in men.11,15 Accordingly, studies investigating the incidence
of LAM in patients with TSC have focused on the female
population. Two recent studies have suggested that LAM in
men with TSC may not be rare. Muzykewicz and colleagues16
conducted a retrospective review of chest CT scans available
on 45 female patients and 20 male patients with TSC. Their
mean age of the entire cohort was 30 years (range, 13e63
years). Cystic lung disease was noted in 22 female patients(49%) and two male patients (10%). Both men with TSC-
related LAM were asymptomatic. In the second study,
Adriaensen and colleagues17 conducted a retrospective
evaluation of CT chest or abdomen for a cohort of 186 adult
patients with TSC which consisted of 95 women and 91 men,
mean age 38 years. One or more cysts were seen in the lung
for 40 women (42%) and 12 men (13%) with TSC.
Cysts in the lung can be associated with many disorders
other than LAM. Diffuse cystic lung diseases include
pulmonary Langerhans cell histiocytosis, Birt-Hogg-Dube´
syndrome, lymphocytic interstitial pneumonia, follicular
bronchiolitis, amyloidosis, light-chain deposition disease,
and rarely, metastatic cancer.18,19 Most of these disorders
are generally distinguishable based on the clinical context
and radiologic features including distribution and associ-
ated findings, e.g., abnormalities involving the intervening
lung parenchyma. In addition, focal or multifocal cystic
lesions can be seen in pulmonary infections, congenital
disorders (e.g., congenital adenomatoid malformation),
and emphysema.18 Since six of our 11 patients with cystic
lung disease had a smoking history, the possibility of
emphysema as an alternative explanation for these lesions
was considered. However, the lesions seen in these patients
were round with identifiable walls and were scattered
throughout the lungs in a random distribution, unlike
smoking-induced emphysematous changes.
We defined cystic lung disease as the presence of 4 or
more cysts in the lungs based on findings in our previous
study.14 It is somewhat surprising that the frequency of
cystic lung disease in men with TSC was similar to that
noted in women with TSC in prior studies.6e8 Our results
suggest a higher frequency when compared to those
described in two recent studies.16,17 We note that our
cohort of TSC patients were older compared to those in the
two prior studies (mean age 42 years vs. 3016 and 3717)
which may, in part, explain the higher frequency in our
study. Many of the clinical features including LAM in
patients with TSC are age-dependent and the prevalence
and severity of LAM increase with age. We suspect that the
lack of a statistically significant difference in the age of
those with cystic lung disease versus those without is likely
due to the limited number of subjects in our study.
Radiologically, the severity of cystic lung disease in
these men was noticeably milder than those previously
described in women with TSC-related LAM.6e8 In experi-
mental models, estrogen promotes proliferation and
metastatic potential of LAM cells as well as their
invasiveness.20e22 These effects of estrogen may explain
the increased severity of LAM in women (higher circulating
level of estrogen) with TSC compared to men.
Our results suggest that the frequency of LAM in men
with TSC may approach that in women with TSC but is of
milder severity. This aspect is also reflected in the prior
study by Adriaensen and colleagues17 in which only 3 of 12
men (25%) with TSC and cystic lung lesions had more than
10 cysts compared to 33 of 40 women (83%). This milder
degree of cystic lung disease was associated with absence
of pleural complications and may partly explain why TSC-
related LAM in men has been under-recognized. Further-
more, patients with TSC have other medical issues that are
more commonly associated with morbidity and mortality
including neurologic manifestations and renal
1590 J.H. Ryu et al.complications. For men with TSC in our study, cystic lung
disease did not appear to be a clinically significant issue.
It should be noted that CT abdomen with limited views of
the lung bases is an inadequatemethod of screening for cystic
lung disease in patients with TSC. Among our 11 patients with
bothCTchest andabdomenavailable for review, fourhad lung
cysts seen on CT chest while CT abdomen detected lung cysts
in only one of these four patients.
There are several limitations to this study which
encompasses a modest number of patients and was limited
to those who had CT scan of the chest or abdomen available
for retrospective analysis. Selection bias including the
tertiary referral nature of our patient population is
a consideration in explaining the unexpectedly high
frequency of cystic lung disease in our cohort of men with
TSC since some of the patients underwent CT scanning
because of respiratory symptoms, chest radiographic
abnormalities or for evaluation of possible LAM. In addition,
the diagnosis of suspected LAM was not histologically
confirmed by lung biopsy. Follow-up and pulmonary func-
tion correlation were limited to few patients.
In conclusion, cystic lung disease consistent with LAM
may not be rare in men with TSC but appears to be rela-
tively mild, particularly when compared to TSC-related LAM
in women.
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